 | • レポートコード：MRC2303F0040 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、258ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：化学 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、2021年に922.11百万ドルであった世界のタンパク質加水分解物市場規模が、2022年に1,003.06百万ドルになり、予測期間中（〜2027年）にCAGR8.95%で成長し1,542.65百万ドルまで達すると展望されています。本書は、タンパク質加水分解物の世界市場について総合的に分析し、市場規模・動向・予測などを整理しています。序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（卵タンパク質加水分解物、海洋性タンパク質加水分解物、肉由来タンパク質加水分解物、植物性タンパク質加水分解物、その他）分析、由来別（動物、微生物、植物）分析、形態別（液状、粉末）分析、エンドユーザー別（動物飼料・栄養、臨床栄養、化粧品・パーソナルケア、食品・飲料、その他）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成で掲載しています。また、主要企業として、Abbott Laboratories、Agrilife、Arla Foods、Arla Foods Ingredients, Inc.、BRISK BIO、Cargill, Incorporated、Danone Nutricia、Fonterra Co-Operative Group Limited、Frieslandcampina、Frieslandcampina DMV、Glanbia Nutritionals, Inc.、Glanbia PLC、Kerry Group plc、Koninklijke DSM N.V.、Nestle S.A.、Roquette Frères S.A.、Tate & Lyle PLC、The Archer Daniels Midland Companyなどの情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のタンパク質加水分解物市場規模：製品別 - 卵タンパク質加水分解物の市場規模 - 海洋性タンパク質加水分解物の市場規模 - 肉由来タンパク質加水分解物の市場規模 - 植物性タンパク質加水分解物の市場規模 - その他の市場規模 ・世界のタンパク質加水分解物市場規模：由来別 - 動物由来タンパク質分解物の市場規模 - 微生物由来タンパク質分解物の市場規模 - 植物由来タンパク質分解物の市場規模 ・世界のタンパク質加水分解物市場規模：形態別 - 液状タンパク質分解物の市場規模 - 粉末タンパク質分解物の市場規模 ・世界のタンパク質加水分解物市場規模：エンドユーザー別 - 動物飼料・栄養における市場規模 - 臨床栄養における市場規模 - 化粧品・パーソナルケアにおける市場規模 - 食品・飲料における市場規模 - その他における市場規模 ・世界のタンパク質加水分解物市場規模：地域別 - 南北アメリカのタンパク質加水分解物市場規模 アメリカのタンパク質加水分解物市場規模 カナダのタンパク質加水分解物市場規模 ブラジルのタンパク質加水分解物市場規模 … - アジア太平洋のタンパク質加水分解物市場規模 日本のタンパク質加水分解物市場規模 中国のタンパク質加水分解物市場規模 インドのタンパク質加水分解物市場規模 韓国のタンパク質加水分解物市場規模 台湾のタンパク質加水分解物市場規模 … - ヨーロッパ/中東/アフリカのタンパク質加水分解物市場規模 イギリスのタンパク質加水分解物市場規模 ドイツのタンパク質加水分解物市場規模 フランスのタンパク質加水分解物市場規模 ロシアのタンパク質加水分解物市場規模 … - その他地域のタンパク質加水分解物市場規模 ・競争状況 ・企業情報 |
The Global Protein Hydrolysates Market size was estimated at USD 922.11 million in 2021 and expected to reach USD 1,003.06 million in 2022, and is projected to grow at a CAGR 8.95% to reach USD 1,542.65 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Protein Hydrolysates to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Egg Protein Hydrolysate, Marine Protein Hydrolysates, Meat Protein Hydrolysates, Milk Protein Hydrolysates, Plant Protein Hydrolysates, Silk Protein Hydrolysate, and Yeast Protein Hydrolysates.
Based on Source, the market was studied across Animals, Microbes, and Plants.
Based on Form, the market was studied across Liquid and Powder.
Based on End Use, the market was studied across Animal Feeds & Nutrition, Clinical Nutrition, Cosmetics & Personal Care, Food & Beverages, Infant Formula, and Sports Nutrition & Dietary Supplements.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Protein Hydrolysates market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Protein Hydrolysates Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Protein Hydrolysates Market, including Abbott Laboratories, Agrilife, Arla Foods, Arla Foods Ingredients, Inc., BRISK BIO, Cargill, Incorporated, Danone Nutricia, Fonterra Co-Operative Group Limited, Frieslandcampina, Frieslandcampina DMV, Glanbia Nutritionals, Inc., Glanbia PLC, Kerry Group plc, Koninklijke DSM N.V., Nestle S.A., Roquette Frères S.A., Tate & Lyle PLC, and The Archer Daniels Midland Company.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Protein Hydrolysates Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Hydrolysates Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Hydrolysates Market?
4. What is the competitive strategic window for opportunities in the Global Protein Hydrolysates Market?
5. What are the technology trends and regulatory frameworks in the Global Protein Hydrolysates Market?
6. What is the market share of the leading vendors in the Global Protein Hydrolysates Market?
7. What modes and strategic moves are considered suitable for entering the Global Protein Hydrolysates Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of gym and sports enthusiasts
5.1.1.2. Demand for product as dietary supplement in Infant nutrition
5.1.1.3. Increasing demand for treatment of various neurological disorders
5.1.2. Restraints
5.1.2.1. High research & development and processing cost
5.1.3. Opportunities
5.1.3.1. Growing retail and E-commerce sector coupled with availability of various protein hydrolysate-based products
5.1.3.2. Increasing awareness among consumers towards health and nutrition
5.1.4. Challenges
5.1.4.1. Adverse health issues due to over consumption
5.2. Cumulative Impact of COVID-19
6. Protein Hydrolysates Market, by Product
6.1. Introduction
6.2. Egg Protein Hydrolysate
6.3. Marine Protein Hydrolysates
6.4. Meat Protein Hydrolysates
6.5. Milk Protein Hydrolysates
6.6. Plant Protein Hydrolysates
6.7. Silk Protein Hydrolysate
6.8. Yeast Protein Hydrolysates
7. Protein Hydrolysates Market, by Source
7.1. Introduction
7.2. Animals
7.3. Microbes
7.4. Plants
8. Protein Hydrolysates Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Powder
9. Protein Hydrolysates Market, by End Use
9.1. Introduction
9.2. Animal Feeds & Nutrition
9.3. Clinical Nutrition
9.4. Cosmetics & Personal Care
9.5. Food & Beverages
9.6. Infant Formula
9.7. Sports Nutrition & Dietary Supplements
10. Americas Protein Hydrolysates Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Protein Hydrolysates Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Protein Hydrolysates Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Agrilife
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Arla Foods
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Arla Foods Ingredients, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. BRISK BIO
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. Cargill, Incorporated
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Danone Nutricia
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Fonterra Co-Operative Group Limited
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Frieslandcampina
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Frieslandcampina DMV
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Glanbia Nutritionals, Inc.
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Glanbia PLC
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Kerry Group plc
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Koninklijke DSM N.V.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Nestle S.A.
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Roquette Frères S.A.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Tate & Lyle PLC
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. The Archer Daniels Midland Company
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing